Huxley Medical, Inc. announced the SANSA(R) home sleep apnea test has received regulatory clearance from the United States Food and Drug Administration (FDA) to be used as a diagnostic ECG monitor, ...

Sleep apnea affects nearly 39 million people in the United States, with many more potentially undiagnosed due to the traditional requirement of a clinical sleep study. However, new options are ...

At-home sleep tests are devices used to screen for sleep apnea. But getting one isn’t as easy as adding it to your cart. You need to talk to your doctor. Taylor Leamey wrote about all things wellness ...

At-home sleep tests are convenient and cheaper than lab studies. But there are some major differences you should know before buying. Taylor Leamey Former Senior Writer Taylor Leamey wrote about all ...

ATLANTA, Ga., June 17, 2025 /PRNewswire/ -- Huxley Medical, a commercial-stage medical technology firm focused on streamlining detection of sleep and heart disorders, announced that the clinical ...

SAN DIEGO, April 03, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced its home ...

NORTH PHILADELPHIA (WPVI) -- Few things are as precious as a good night's sleep. People who snore, gasp, or stop breathing may fear overnight testing in a sleep lab. There's been a revolution in ...

(RTTNews) - ResMed Inc.(RMD), announced Thursday that its NightOwl home sleep apnea test or HSAT is now available across the United States, providing a simple and effective at-home diagnostic solution ...

TAMPA, Fla.--(BUSINESS WIRE)--Sleep technology company REMware™ has signed an agreement with Side Health, a national chronic care management company, to provide sleep apnea testing services to meet ...

Acurable, a U.K.-based medical device company, announced it raised €11 million ($10.8 million) in a Series A funding round led by Kibo Ventures. Mundi Ventures, Comprador Holdings and Kindred Capital ...